CN
EN
TC
About Us
About Us
Management Team
Our Culture
Our History
Business Conduct and Ethics
ESG
Award and Recognition
Media Center
Platform
Peptide CRDMO Platform
Oligonucleotide CDMO Platform
News
Press Release
Events
Careers
Talent Outlook
China Opportunities
Contact Us
Investors
Listing Documents
Financial Reports
Announcements & Notices
Corporate Governance
Press Release
Events
2026-05-11
Good News | Medtide Inc.’s Subsidiary Chinese Peptide Company Sees Triptorelin Pamoate API Accepted for CDE Registration, Adding a New Product to Its Peptide Hormone Regulatory Portfolio
More
2026-03-19
Medtide Inc. Awarded “Leading Enterprise” in the 2026 Forbes China Industry Development Pioneers Selection
More
2025-06-30
Warm Congratulations | Medtide Inc. Successfully Listed on the Hong Kong Stock Market!
More
Chinese Peptide Company, Medtide Subsidiary, Receives National 'Little Giant' Designation
More
Chinese Peptide Company, Medtide Subsidiary, Clears FDA On-Site Inspection
More
Chinese Peptide Company, Medtide Subsidiary, Earns Australian TGA GMP Certification
More
Prev
1
2
Next
